Kabat Rehabilitation Versus Mime Therapy on Facial Disability and Synkinesis in Patients of Bell's Palsy

NCT06029855 | Completed DMC

• 1 other identifier: REC-UOL-406-05-2023
• Study Type: interventional
• Target: 85
• Locations: 1 country
• Sites: 1

Brief Summary

Bell's palsy, also called idiopathic facial paralysis, is a common cause of unilateral facial paralysis. It is one of the most common neurological disorders of the cranial nerves.

Conditions

Bell Palsy

Keywords

Bell Palsy; Kabat Rehabilitation; Mime Therapy

Outcome Measures

Primary Outcomes (2)

• Change in Synkinesis

  Synkinesis will be accessed through the "House-Brackmann Scale". It is classified as a universal scale. This scale analyses the symmetry, synkinesis, stiffness, and global mobility of the face. It is divided into six categories (normal, mild dysfunction, moderate dysfunction, moderately severe dysfunction, severe dysfunction, and total paralysis) and is a 0-6-point scale with 6 representing total paralysis.

  It will be assessed at baseline, at the third week and at six week.

• Level of Facial Disability

  The level of Facial disability will be measured through the "Facial Disability Index Scale". This scale has ten items that evaluate the patient's physical and social aspects (mastication, deglutition, communication, labial mobility, emotional alterations, and social integration). It uses a hundred-point scale with a higher score indicating less impairment. 24 Minimum score for physical functioning: 0, Maximum score for physical functioning: 25, Minimum score for social and well-being: 5, Maximum score for social and well-being.

  Change in functional status will be measured at the baseline, at 3rd week and at 6th week.

Study Arms (2)

Kabat Therapy

ACTIVE COMPARATOR

Kabat exercises primarily assist functional response in defective muscles through the general structure of muscles experiencing resistance. After 6th week, resting and voluntary symmetries were recorded.

Other: Kabat Therapy

Mime Therapy

EXPERIMENTAL

Mime therapy utilizes emotional input to access better movement patterns. It is beneficial as it improves circulation and maintains muscle properties.

Other: Mime Therapy

Interventions

Kabat Therapy OTHER

The participants of group A will receive Kabat Rehabilitation with routine physical therapy. The protocol will be given to the participants for three sessions/week for six weeks. Each session will be of 30 minutes.

Kabat Therapy

Mime Therapy OTHER

The participants of group B will receive Mime Therapy in addition to routine physical therapy. The protocol will be given to the participants once a week for six weeks, while physical therapy will be given on alternate days. Each session will be of 30 minutes.

Mime Therapy

Eligibility Criteria

• Age: 25 Years - 50 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Age group 25-50 years.
• Both male and female.
• Unilateral bell's paralysis.
• Not congenital in origin.
• Sub-acute and chronic cases.

You may not qualify if:

• Other neurological deficits include epilepsy and Alzheimer's disease.
• Traumatic onset.
• Surgical reconstruction (nerve or muscle reconstruction).
• Mental and psychological disorders i.e., schizophrenia, bipolar disorders.
• Skin diseases (eczema, urticarial) as electrical stimulation may affect the results.
• Any contraindications for massage like sunburn, bruising, or cuts.

Sponsors & Collaborators

• University of Lahore: lead

Study Sites (1)

The University of Lahore

Lahore, Punjab Province, 5400, Pakistan

Location

Related Publications (1)

• Amjad A, Jamil A, Fatima N, Javaid HB, Zahid H. Effects of Kabat rehabilitation versus mime therapy on facial disability and synkinesis in patients of Bell's palsy. J Pak Med Assoc. 2024 Nov;74(11):1927-1931. doi: 10.47391/JPMA.11247.

  PMID: 39548608 DERIVED

MeSH Terms

Conditions

Bell Palsy

Condition Hierarchy (Ancestors)

Herpesviridae Infections; DNA Virus Infections; Virus Diseases; Infections; Mouth Diseases; Stomatognathic Diseases; Facial Nerve Diseases; Cranial Nerve Diseases; Nervous System Diseases

Study Officials

• Ashfaq Dr Ahmed, PhD

  University of Lahore

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 1, 2023
• First Posted: September 8, 2023
• Study Start: May 1, 2023
• Primary Completion: September 30, 2023
• Study Completion: October 15, 2023
• Last Updated: March 28, 2025

Record last verified: 2025-01

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: Immediately after publication

Locations

PA (1)